ORBIMED ADVISORS LLC 13D and 13G filings for Turning Point Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-04-07 4:39 pm Sale |
2021-03-01 | 13D | Turning Point Therapeutics, Inc. TPTX |
ORBIMED ADVISORS LLC | 1,743,950 3.600% |
-283,600 (-13.99%) |
Filing |
| 2020-05-22 4:54 pm Unchanged |
2020-05-21 | 13D | Turning Point Therapeutics, Inc. TPTX |
ORBIMED ADVISORS LLC | 2,027,550 4.900% |
0 (Unchanged) |
Filing |